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Aims: This study analyzed the arrhythmogenic substrates and mechanisms of ventricular
tachycardia (VT), and long-term outcomes of catheter ablation in patients with arrhyth-
mogenic right ventricular cardiomyopathy/dysplasia (ARVC/D).
Methods: Nine patients (1 female, 40717 years) with ARVC/D and sustained monomorphic
VT (SMVT) exhibiting left bundle branch block morphology of the QRS complex were
studied. The diagnosis of ARVC/D was confirmed by means of echocardiography, magnetic
resonance imaging, and electroanatomic mapping in all patients.
Results: The patients underwent 10 ablation procedures. At the initial ablation, the mean
VT rate was 196721 (170–240) bpm. In total, 17 VT types were observed. One VT type with
left axis (þI, aVL), or right axis (þII,III,aVF) of the QRS complex was present in 3 and 1
patient, respectively. Two VT types of left and intermediate (þI, II, aVL) axis or of left and
right axis of the QRS complex were observed in 3 and 2 patients, respectively. Multiple VT
types with left axis QRS complex recurred in 1 patient. One VT displayed characteristics of
focal arrhythmia, the mechanism of remaining VTs was clearly macroreentrant. The
critical slow-conducting isthmus of the reentry circuit was located at the infero-lateral
aspect of tricuspid annulus and was bounded by the annulus and baso-lateral wall scar in 7
VTs; the isthmus was located within the scars in the remaining VTs. During 52731 (12–93)
month follow-up since the last ablation, 8 (89%) patients remained free from any VT
recurrence without antiarhythmic drug.
Conclusions: Patients with ARVC/D frequently presented Z1 SMVT type. The critical
isthmus of reentry circuit was dominantly located close to the tricuspid annulus. Long-
term outcome of extensive endocardial ablation was favorable with isolated VT recur-
rences in one patient.
& 2012 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
.ch Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All rights reserved.
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c o r e t v a s a 5 5 ( 2 0 1 3 ) e 1 5 – e 2 4e161. Introduction
Arrhythmogenic right ventricular cardiomyopathy/dysplasia
(ARVC/D) represents a genetically determined hereditable
disorder afflicting predominantly right ventricle (RV). Patchy
replacement of myocytes by adipose and fibrous tissue
may result in ventricular tachycardia (VT)/fibrillation, sudden
cardiac death, and RV failure [1,2]. Despite implantation of
automatic cardioverter-defibrillator (ICD) as the therapeutic
mainstay to prevent sudden cardiac death, catheter ablation
is often necessary to reduce arrhythmic burden and improve
quality of life [3–5]. Although ARVC/D is a progressive disease,
progression of structural changes may be relatively slow or
step-like in some patients [6], and successful ablation may
eliminate arrhythmia recurrences for years. Epicardial abla-
tion approach may become necessary in some patients [5,7,8];
however, meticulous endocardial RV mapping and extensive
ablation including the peri-tricuspid rim can be successful in
a substantial proportion of patients.
This retrospective study of catheter ablation of VT in ARVC/D
aimed at investigating the arrhythmogenic substrates,
VT mechanisms, and ablation outcomes in one center over
8 years.
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.2. Methods
The study included 9 patients (1 female) aged 40717 (17–71)
years with ARVC/D and sustained monomorphic VT (SMVT).
These patients represented 8% of 110 patients undergoing
catheter ablation of SMVT associated with structural heart
disease in one center between January 2004 and August
2011. All patients fulfilled the major arrhythmic criterion of
ARVD/C in terms of SMVT with left bundle branch block
(LBBB) morphology and superior axis of the QRS complex
(Table 1). ARVC/D was also confirmed by means of echocar-
diography and magnetic resonance imaging (MRI) in all
patients. Presence of echocardiographic, MRI, and additional
electrocardiographic criteria indicative of ARVC/D according
to the revised task force proposal [9] is shown in Table 2. Left
ventricular ejection fraction was in normal range in all except
one patient, and coronary angiography was negative in all
patients in whom it was performed. Two patients (]1 and 9)
presented with the family history of sudden cardiac death in
young male relatives. Four (44%) patients underwent ablation
after the first documented VT episode, 3 (33%) patients were
referred to catheter ablation following VT recurrences, and 2
(22%) patients due to frequent recurrent VT despite chronic
use of amiodarone with discharges of already implanted ICD.
Individual baseline characteristics are shown in Table 1.
For the electrophysiological study, a 4-pole catheter (Biosense
Webster, Diamond Bar, CA, USA) was introduced into the RV for
pacing, a 10-pole catheter (Daig, St. Jude, Minnetonka, MN,
USA) was positioned in the coronary sinus, and a mapping/
ablation catheter (NaviStar ThermoCool, Biosense Webster)
was inserted via 8 F long sheath (Mullins fixed curve, Daig, St.
Jude) in the RV. Bipolar endocardial electrograms were filtered
at a band-pass setting of 30–500 Hz and displayed on the
Cardiolab System (Prucka Engineering, Sugar Land, TX, USA).
Table 2 – Echocardiographic, MRI, and ECG criteria of ARVC/D.
N. pt 2D Echo criteria MRI criteria Depolarization abnormalities Repolarization abnormalities
Major Minor Major Minor Major Minor Major Minor
1 þ þ þ
2 þ þ þ
3 þ þ
4 þ þ þ þ
5 þ þ þ þ
6 þ þ þ þ
7 þ þ þ þ
8 þ þ þ þ
9 þ þ þ
ARVC/D¼arrhythmogenic right ventricular cardiomyopathy/dysplasia; pt¼patient; Echo¼echocardiographic; MRI¼magnetic resonance
imaging.
Fig. 1 – Electroanatomic mapping of the right ventricle (roughly right oblique projection) during ongoing ventricular tachycardia
with LBBB morphology and left axis deviation (þI, aVL) on standard 12 lead ECG (50 mm/s; Panel A; patient ]1). Activation
mapping (Panel B) indicates the location of critical slow-conducting isthmus close to infero-lateral tricuspid annulus, where the
latest activation at the superior entrance into the isthmus (coded in purple) meets the earliest activation at the inferior exit from
the isthmus (coded in red), and where isolated mid-diastolic potentials shown by arrows are recorded during the tachycardia by
the mapping/ablation catheter (ABL) on Panel D. The tachycardia impulse propagates over a double reentry circuit simultaneously
around the tricuspid annulus and around the baso-lateral scar that is coded in red on the voltage map (Panel C). Atrial potentials
recorded by catheter in the coronary sinus (CS) are dissociated from the ventricular potentials. RVa¼recording from the right
ventricular apex; TA¼tricuspid annulus. ECG speed on Panel D 100 mm/s. (For interpretation of the references to color in this
figure legend, the reader is referred to the web version of this article.)
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 1 5 – e 2 4 e17The study protocol was commenced with standard pro-
grammed and incremental ventricular pacing with the aim
to induce all VT types (all VT QRS complex morphologies
and rates) that were subsequently targeted by mapping and
ablation. Hemodynamically tolerated VTs were preferentially
mapped selectively during the ongoing arrhythmia usingelectroanatomic activation mapping (CARTO system, Bio-
sense Webster; Fig. 1). Simultaneously, detailed bipolar vol-
tage electroanatomic RV reconstruction was accomplished
using the voltage criteriao0.5 mV to identify scar (low voltage
area of fatty/fibrous tissue) and 41.5 mV to identify normal
myocardium, so that all possible anatomical conduction
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 1 5 – e 2 4e18barriers were delineated. In addition, the sites of diastolic
potentials were tagged, and entrainment mapping was sub-
sequently applied to confirm the location of critical slow-
conducting isthmus within the conduction barriers. In case of
hemodynamically unstable VT, electroanatomic RV recon-
struction during sinus rhythm was completed to identify
gross RV anatomy and possible anatomical conduction bar-
riers (Fig. 2). Late potentials were further recorded and
tagged. Then pace-mapping was performed to identify theFig. 2 – The figure shows an example of a pair of ventricular tach
(patient ]7). The pair of ventricular tachycardia exhibits the sam
Panel A) or left-axis QRS complex (þI, aVL; Panel C). These tach
reentry circuit alternately in the opposite directions as schema
isthmus of slow conduction was located between an extensive r
electroanatomic map in panels B and D) and the tricuspid annu
complex, respectively, the electric impulse exited the critical ist
sites are marked by yellow asterisks). PA¼pulmonary annulus
voltage41.5 mV on the electroanatomic voltage maps was coded
in this figure legend, the reader is referred to the web version ocentral part of critical isthmus of slow conduction (pace-
mapping with QRS complex matching the VT QRS complex in
all 12 leads and long stimulus-QRS complex interval), and the
exit from critical isthmus (pace-mapping with QRS complex
matching the VT QRS complex in all 12 leads and zero
stimulus-QRS complex interval). Finally, if the patient par-
tially tolerated VT, following identification of the VT critical
isthmus by mapping during sinus rhythm, the VT was
induced for a short time to prove that the late potentialsycardia that was approached by substrate mapping/ablation
e rate, and alternating right-axis QRS complex (þII, III, aVF;
ycardias resulted from rotation over the same double-loop
tically depicted by black arrows on Panels B, D. The critical
ight ventricular baso-lateral scar (coded in red on the voltage
lus (TA). During the tachycardia with right or left axis QRS
hmus either superiorly (Panel B) or inferiorly (Panel D) (exit
, TA¼tricuspid annulus. Normal myocardium displaying
in purple color. (For interpretation of the references to color
f this article.)
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 1 5 – e 2 4 e19recorded during sinus rhythm corresponded to the mid-
diastolic potentials during ongoing VT, and that the VT could
be terminated by ablation at that site (Fig. 3). Irrespective of
the primary mapping approach (selective or anatomically
guided), ablation was always extended across the whole
critical isthmus(mi) and all late potentials were eliminated.
At the end of the study, complete standard protocol of
programmed ventricular pacing was repeated to prove non-
inducibility ideally of any VT. Radiofrequency energy was
applied with a Stockert generator (Biosense Webster). We
used irrigation of 30 ml/min (heparinized 0.9% saline) and
temperature and power limits of 42 1C and 50 W respectively.Fig. 3 – The figure shows an example of late potentials (red arrow
catheter (ABL, ABL d) during sinus rhythm at the critical slow-c
lateral scar and tricuspid annulus (patient ]7; Panel A). During
(red arrows) were recorded at the same site, and subsequent ab
recording from the right ventricular apex; ECG speed¼100 mm/
legend, the reader is referred to the web version of this article.3. Results
3.1. Ablation procedure characteristics and immediate
results
The nine patients underwent a total of 10 ablation proce-
dures. Procedure, fluoroscopy, and radiofrequency delivery
times were 199757 (120–300) minutes, 1076 (4–21) minutes,
and 32726 (11–94) minutes, respectively. All 9 initial ablation
procedures were completed with noninducibility of any VT. In
one patient (#6), other types of SMVTrecurred 1 year later ands) recorded by the proximal and distal bipole of the ablation
onducting isthmus located between right ventricular baso-
induced ventricular tachycardia, mid-diastolic potentials
lation terminated the tachycardia (panel B). RVa d¼bipolar
s. (For interpretation of the references to color in this figure
)
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c o r e t v a s a 5 5 ( 2 0 1 3 ) e 1 5 – e 2 4e20the patient underwent a repeat ablation for multiple SMVTs.
This procedure eliminated several SMVT types, while 1 type
of fast SMVT remained inducible despite repeat VT termina-
tion with radiofrequency application (details in Table 3).
3.2. Electrophysiological findings
3.2.1. Morphologies of ventricular tachycardia
In total, 14 VT types of LBBB morphology were observed
during the first ablation procedure (Table 3). At the initial
ablation, the mean VT rate was 196721 (170–240) bpm. One
VT type of left axis QRS complex (þI, aVL) was present in 3
patients, and one VT type of right axis QRS complex
(þII,III,aVF) was found in 1 patient. Two VT types of left and
intermediate (þI, II, aVL) axis QRS complex were observed in
3 patients, and 2 VT types of left and right axis QRS complex
were present in another 2 patients (Table 3; Figs. 4 and 5).
When 2 VT types were observed spontaneously or were
induced by ventricular pacing, they usually represented a
pair of VTs of the same rate rotating alternately in both
directions around one reentry circuit that was eliminated by
ablation of one common critical slow-conducting isthmus
(Fig. 2). At repeat ablation, several SMVT types displaying
positive QRS complex in leads I, aVL or in leads aVR, aVL were
induced in one patient (Table 3; Fig. 6).
3.2.2. Sites of origin of ventricular tachycardia
At first ablation, VT types with left axis of the QRS complex
(n¼8) originated from an inferior exit of the critical isthmus
close to TA (n¼5) (Fig. 1), from an inferior exit of the critical
isthmus traversing through the RV baso-lateral scar (n¼2),
and from the critical isthmus between basal infero-lateral
scar and infero-apical scar (n¼1). VT types with right axis of
the QRS complex (n¼3) originated from a superior exit of the
critical isthmus close to TA (n¼1) (Fig. 2), or from a superior
exit of the critical isthmus traversing through the RV baso-
lateral scar (n¼1). In addition, 1 incessant irregular VT with
right axis deviation of the QRS complex originated from a
localized source within the high anterior scar in one patient
(patient #6; Fig. 4). Finally, VT types with intermediate QRS
complex axis (n¼3) arose from a superior exit of the critical
isthmus close to TA when the baso-lateral scar constituting
the other conduction barrier was located rather inferiorly
(n¼1), or from a mid-level exit from the critical isthmus
traversing through the baso-lateral scar (n¼2) (Fig. 5).
3.2.3. Critical isthmi of reentry circuits
The critical isthmi of slow conduction were found between
the TA and baso-lateral scar in 5 patients. They were formed
by relatively narrow slow-conducting channels abutting to
the TA laterally (n¼1), inferolaterally (n¼3), and inferiorly
(n¼1) depending on the more superior or inferior location/
extension of the baso-lateral scar (Figs. 1 and 2). In another 3
patients, the critical slow-conducting isthmus traversed
through the baso-lateral scar (n¼2) (Fig. 5). Finally, the critical
isthmus between the basal infero-lateral scar and infero-
apical scar was observed in 1 patient (1 VT type in patient ]8).
Extensive infero-apical scar formed the source of multiple VT
types displaying basically two axes of the QRS complex with
different rates in patient ]6 at repeat ablation (Fig. 6).
Fig. 4 – The figure shows an example of a ‘‘focal’’ ventricular tachycardia. Patient ]6 initially presented with one type
of incessant irregular VT displaying right axis of the QRS complex (Panel C) that originated from the high anterior right
ventricular scar, exhibited centrifugal endocardial activation of the rest of right ventricle (Panels A and B), and was
eliminated by focal ablation at the site of earliest activation marked in red on activation map (Panel B). Panel A shows voltage
map in the same projection, where red color coded areas with voltageo0.5 mV (scars). Location of high anterior scar on
the voltage map (Panel C) spatially correlated with the site of earliest activation on the activation map (Panel B). (For
interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Fig. 5 – Electroanatomic map of the right ventricle (in roughly right oblique projection) during ongoing ventricular
tachycardia with intermediate axis (þI, II, aVL) of the QRS complex on standard 12 lead ECG (Panel A; patient ]3).
Activation mapping (Panel B) indicates location of the critical slow-conducting isthmus close to lateral aspect of the tricuspid
annulus, where the latest activation at the site of inferior entrance into the isthmus (coded in purple) meets the earliest
activation (coded in red) at the site of exit from the isthmus (traversing obliquely through the scar) at the medium-level basal
lateral right ventricular wall. At the site of critical isthmus, isolated mid-diastolic potentials shown by arrows are recorded
by mapping/ablation catheter (ABL) during the tachycardia (panel D). Voltage mapping (Panel C) shows an extensive baso-
lateral scar coded in red, while normal myocardium exhibiting voltage41.5 mV is coded in purple color. Atrial potentials
recorded by catheter in the coronary sinus (CS) are dissociated from the ventricular potentials. RVa¼recording from the right
ventricular apex; TA¼tricuspid annulus. ECG speed on Panel D 200 mm/s. (For interpretation of the references to color in this
figure legend, the reader is referred to the web version of this article.)
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 1 5 – e 2 4 e21
Fig. 6 – Electroanatomic voltage map of the right ventricle
shows in roughly right oblique projection an extensive scar
stretching from inferior across lateral to anterior right
ventricular wall (voltageo0.5 mV coded in red) (Panel A;
patient ]6). Septum exhibited normal myocardium with
voltage41.5 mV coded in purple (Panel B). Multiple types of
ventricular tachycardia were targeted at inferior and infero-
apical wall, where white dots mark the sites of late
potentials during sinus rhythm. Basically four types of VT
morphologies were observed, some of which occurred with
various rates. Type 1 VT (rate 120 bpm; Panel C), type 2 VT
(rate 230–260 bpm; Panels F,G), and type 3 VT (330 bpm)
were targeted at the basal inferior wall, type 4 VT (rate
160–210 bpm; Panel D,E) arose from the infero-apical
segment. These tachycardias newly developed despite
achieving noninducibility of any ventricular
tachyarrhythmia at the end of prior procedure after ablation
of ventricular tachycardia originating at the anterior wall
(see Fig. 4). OT¼outflow tract, TA¼tricuspid annulus. (For
interpretation of the references to color in this figure legend,
the reader is referred to the web version of this article.)
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 1 5 – e 2 4e223.3. Long-term outcome
During the long-term follow-up of 52731 (12–93) months
since the last ablation, 6 patients received ICD (4 patientsafter the successful ablation), while 3 patients declined
ICD implantation. Eight (89%) patients with single ablation
remained free from any VT recurrence without class I or III
antiarrhythmic drug. SMVT recurred in only 1 patient, who
continues medication with sotalol (patient ]6) and who
experienced two isolated SMVT episodes during 26-month
follow-up after the last ablation. These VT recurrences were
terminated by overdrive pacing from ICD (Table 3).4. Discussion
This study retrospectively analyzed long-term results of radio-
frequency catheter ablation of SMVT in patients with ARVC/D.
The major findings of the study are as follows: (1) Patients with
ARVC/D-related SMVT represented 11% of all patients with
structural heart disease, who underwent VT ablation; (2) More
than half of the patients presentedwithZ1 SMVT type, mostly a
pair of SMVT alternately rotating around one reentry circuit in
both directions; (3) The critical isthmus of slow conduction was
dominantly located along lateral-to-inferior aspect of the TA
bounded by the TA on one side and by the baso-lateral scar on
the other side; (4) Meticulous RV mapping including the peri-
tricuspid rim identified the SMVT source in all the patients; (5)
Long-term outcome of extensive endocardial ablation was favor-
able with isolated VT recurrences in one patient.
ARVC/D is a relatively rare condition with estimated preva-
lence ranging between 0.05% and 0.02% of the total population
[2,10]. In this study, patients with ARVC/D-related SMVT repre-
sented 11% of all patients with VT ablation due to major
structural heart disease, which was more than expected based
on the ARVC/D prevalence. One possible explanation of this
discrepancymay lie in the early indication to catheter ablation of
ARVC/D-related SMVT, often after the first documented SMVT
episode, as it was considered a reasonable initial therapeutic step
because of patient’s age, probability of further VT recurrences,
and potential need for AAD therapy. On the contrary, catheter
ablation of VT in the setting of prior myocardial infarction or
dilated cardiomyopathy was usually resorted to after ICD had
been implanted and all conventional therapeutic options includ-
ing amiodarone to suppress frequent VT recurrences had failed.
If ablation in patients with other major structural heart diseases
had been implemented earlier, the proportion of patients with
ARVC/D-related SMVTwould have been lower.
Prior studies employing endocardial VT ablation reported
partly diverse results in relatively small ARCV/D populations
ranging from 11 to 24 patients [3,4,11–13]. Worst outcomes were
presented when a majority of ablation procedures were per-
formed conventionally (79%) leading to only 23% success rate in
achieving immediate elimination of all inducible VTs, and very
low 25% VT recurrence-free survival after the 14-month follow-
up period [12]. On the other hand, and similar to our results,
using electroanatomic or non-contact 3-dimensional mapping,
most of the induced VTs were eliminated by ablation and
following repeat ablation, nearly 90% of the patients remained
free from VT long-term, while the remaining patients experi-
enced only rare VT recurrences [3,13].
In the prior studies, the critical slow-conducting isthmi were
frequently found very close to the TA and were bounded by the
TA and RV baso-lateral scar. Other possible boundaries of the
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tract scar or by two separate free-wall scars [3,4,11]. In our
patients, the critical isthmi located at the para-tricuspid rim
stretched from lateral to inferior aspect of the TA depending
individually on the extent and/or location of baso-lateral RV scar.
They were often relatively narrow and abutted the TA very
closely so that distinct atrial potentials were typically recorded
at the successful ablation site. It is likely that without meticulous
mapping and ablation of the TA itself some of these VT sources
might have been missed or VT would have recurred due to
inadequate isthmus transsection.
In 1 patient, focal source of VTwas observed. This VT arose
from inside the low-voltage area (scar), and its mechanism
has remained speculative, as the VT presented as incessant,
slightly irregular arrhythmia interrupted by periods of sinus
rhythm, suggesting rather ectopic origin. RV free-wall loca-
lized VT sources in ARVC/D patients have been previously
described to be associated with a relatively low 50% success
rate of endocardial ablation [11]. Limited efficacy of ablation
of these ‘‘focal’’ VTs may stem from the fact that they may
represent only endocardial breakthrough with endocardial
centrifugal activation pattern, while the entire reentrant
circuit is located epicardially [14]. Epicardial substrate was
suspected in our patient with ‘‘focal’’ VT in whom later
multiple different SMVTs recurred despite noninducibility of
any VT at the end of the initial ablation. Besides the
ambiguity of the primary ‘‘focal’’ VT mechanism, presence
of progressive endo-epicardial substrate was supported by
the course of repeat ablation when one VT type remained
inducible despite repeated delayed termination during radio-
frequency energy delivery.
Findings from autopsy examinations and endocardial–
epicardial electroanatomic mapping studies showed that
arrhythmogenic substrate in ARVC/D may be more extensive
epicardially than endocardially [15,16]. Recent studies further
proposed that more extensive epicardial voltage abnormalities
may be identified by endocardial electroanatomic mapping [17],
and that delayed epicardial activation from combined endocar-
dial and epicardial mapping may suggest VT circuits contained
entirely within the epicardium [18]. In addition, there has been
increasing evidence that some of the VTs can be eliminated only
by epicardial ablation approach [5,16,19,20]. Epicardial ablation
successfully eliminated VT in 77% of the patients with prior
failed endocardial ablation, and additional 15% of the patients
had only single VT recurrence [19]. Further, combined endocar-
dial and epicardial catheter ablation employed as the primary
strategy lead to the VT noninducibility in all patients with
subsequent 91% VT-free long-term outcome [16]. One study
randomizing 49 ARVC/D patients to primary combined endo-
epicardial substrate-based ablation versus sole endocardial abla-
tion proved superiority of the former approach by showing long-
term freedom from ventricular arrhythmias in 85% of the
patients, whereas only 52% of the patients with endocardial
ablation remained free from further VT recurrences (P¼0.029)
[20]. Finally, long-term outcomes in 87 ARVC/D patients from 80
different centers showed better VT-free survival at 5 years when
epicardial ablation was involved compared to endocardial abla-
tion alone [5].
In our patients, favorable outcomes of pure endocardial
ablation may be partly related to relatively extensive andaggressive ablation employed from the initial stages of our
experience. The results were achieved in ARVC/D patients
exhibiting similar profile in baseline characteristic as in
above mentioned prior studies including preponderance of
males and mean age. Noninducibility of any VTwas achieved
in all patients at the first ablation procedure. Only 1 patient
with suspected early progression of the RV structural
changes, who required repeat ablation for newly developed
distinct SMVT types, experienced 2 isolated SMVT recur-
rences during long-term follow-up (see also above). These
findings indicate possible slow progression of the dysplastic
changes, or long periods of entire remission in some patients
or at some stages of the disease [6].
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